Biotech is increasingly embracing the fact that as an innovation industry delivering tomorrow's medicines, it derives huge value from an incredibly vibrant talent base among immigrants, people of color, LGBTQ people, and an array of other minority groups. And they bring more than their individual skills to the job. It has been qualitatively documented that diverse perspectives enrich companies' pursuits; different ways of thinking help break old paradigms. These panelists represent D&I managers or ERG representatives from a spectrum of companies investing heavily in representational workforces as cultural and innovation priorities, as well as the industry's largest LGBTQ non-profit. They will share their perspectives on how the industry's appreciation for D&I is changing, and give practical advice for developing D&I policies and corporate cultures that acknowledge and raise up diverse perspectives to the enrichment of all.